再生療法的全球市場:各組織類型，各應用領域，各終端用戶，各地區-規模，佔有率，展望，機會分析(2022年～2028年)

組織工程和生物醫生工程缺乏相關標準化指南，阻礙全球再生療法市場成長。還有臨床試驗花費時間，產品上市延遲，也成為抑制市場成長的要素。

本報告提供全球再生療法市場的相關調查，市場展望，市場動態，市場分析，競爭情形等全面性資訊。

目錄

第1章 調查目的、前提條件

• 調查目的
• 假設
• 簡稱

第2章 市場展望

• 報告的說明
  • 市場定義和範圍
• 摘要整理
  • 市場明細:各組織類型
  • 市場明細:各應用領域
  • 市場明細:各終端用戶
• Coherent Opportunity Map(COM)

第3章 市場動態，法規，及趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 主要的開發
• 法規情境
• PEST分析

第4章 全球再生療法市場:各組織類型(100萬美元)(2017年～2028年)

• 簡介
• 同類移植
• 異種移植
• 無生物材料移植

第5章 全球再生療法市場:各應用領域(100萬美元)(2017年～2028年)

• 簡介
• 軟組織的修復
• 心血管
• 牙科
• 整形外科
• 中樞神經系統疾病的治療
• 其他

第6章 全球再生療法市場:各終端用戶(100萬美元)(2017年～2028年)

• 簡介
• 醫院
• 門診病人手術中心
• 教育機關

第7章 全球再生療法市場:各地區(100萬美元)(2017年～2028年)

• 簡介
• 北美
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他的歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東南亞國協
• 澳洲
• 韓國
• 其他的亞太地區
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他的南美
• 中東
• GCC各國
• 以色列
• 其他的中東
• 非洲
• 北非
• 中非
• 南非

第8章 競爭情形

• 企業簡介
• Shire Pharmaceuticals
• Kinetic Concepts, Inc.
• Mesoblast Ltd.
• Nuo Therapeutics(Cytomedix Inc.)
• Advanced Cell Technology, Inc.
• BioStem Life Sciences
• Akron Biotechnology, LLC
• Organovo Holdings Inc.
• Orgenesis Inc.
• Pluristem Therapeutics Inc.
• Genzyme
• Athersys, Inc.
• RenovaCare, Inc.
• Cytori Therapeutics, Inc.

第9章 Section

• 參考文件
• 調查手法
• 關於本公司與營業窗口

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:

Allograft

Xenograft

Alloplast

Global Regenerative Therapies Market, By Application:

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

Global Regenerative Therapies Market, By End User:

Hospitals

Ambulatory Surgical Centers

Educational Institutes

Global Regenerative Therapies Market, By Geography:

North America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.S.

Canada

Europe

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

GCC

Israel

Rest of Middle East

Africa

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Shire Pharmaceuticals *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Kinetic Concepts, Inc.

Mesoblast Ltd.

Nuo Therapeutics (Cytomedix Inc.)

Advanced Cell Technology, Inc.

BioStem Life Sciences

Akron Biotechnology, LLC

Organovo Holdings Inc.

Orgenesis Inc.

Pluristem Therapeutics Inc.

Genzyme

Athersys, Inc.

RenovaCare, Inc.

Cytori Therapeutics, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
  • Executive Summary
• Market Snippet, By Tissue Type
• Market Snippet, By Application
• Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Allograft
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Xenograft
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Alloplast
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends

5. Global Regenerative Therapies Market, By Application, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Soft Tissue Repair
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cardiovascular
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Dental
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Orthopedic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • CNS disease treatment
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Regenerative Therapies Market, By End User, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ambulatory Surgical Centers
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Educational Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Regenerative Therapies Market, By Regions, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
• Shire Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kinetic Concepts, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mesoblast Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nuo Therapeutics (Cytomedix Inc.)
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Cell Technology, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioStem Life Sciences
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akron Biotechnology, LLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Organovo Holdings Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Orgenesis Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pluristem Therapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genzyme
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Athersys, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• RenovaCare, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cytori Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact